Literature DB >> 33610127

Breast MRI in DCIS size estimation, breast-conserving surgery and oncoplastic breast surgery.

Alexander Bartram1, Fiona Gilbert2, Alastair Thompson3, G Bruce Mann4, Amit Agrawal5.   

Abstract

The impact of MRI on improving surgical outcomes in DCIS is debated. Here, we explore the utility of MRI in the investigation and management of DCIS in three key areas. Firstly, we highlight that MRI is likely to be a more accurate predictor of actual tumour size than conventional imaging. Secondly, we examine mastectomy rates and reoperation rates across the literature and suggest that surgical outcomes do not differ between pre-operative MRI and conventional imaging groups, despite improved size estimation on MRI. Finally, we examine the rapidly developing field of oncoplastic breast surgery and highlight a paucity of data in determining the usefulness of pre-operative MRI in this field, despite this being an oncologically safe alternative with improved patient outcomes and satisfaction. Crown
Copyright © 2021. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast MRI; Breast cancer; Ductal carcinoma in situ; Mastectomy; Oncoplastic; Surgery

Mesh:

Year:  2021        PMID: 33610127     DOI: 10.1016/j.ctrv.2021.102158

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  3 in total

Review 1.  Ductal Carcinoma in Situ: State-of-the-Art Review.

Authors:  Lars J Grimm; Habib Rahbar; Monica Abdelmalak; Allison H Hall; Marc D Ryser
Journal:  Radiology       Date:  2021-12-21       Impact factor: 11.105

Review 2.  The accuracy of magnetic resonance imaging in predicting the size of pure ductal carcinoma in situ: a systematic review and meta-analysis.

Authors:  Ricardo Roque; Mariana Robalo Cordeiro; Mónica Armas; Francisco Caramelo; Filipe Caseiro-Alves; Margarida Figueiredo-Dias
Journal:  NPJ Breast Cancer       Date:  2022-06-29

3.  Overcoming Barriers in Ductal Carcinoma In Situ Management: From Overtreatment to Optimal Treatment.

Authors:  Jean L Wright; Habib Rahbar; Samilia Obeng-Gyasi; Ruth Carlos; Judy Tjoe; Antonio C Wolff
Journal:  J Clin Oncol       Date:  2021-11-23       Impact factor: 50.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.